Physician
Hematology
Dr. William S. Velasquez, MD
|
|
Give Review
William Velasquez works in the field of Hematology. He went to medical school at University Hospital - University of Cincinnati College of Medicine. He received awards:"Fellow (FACP)". Doctor William S. Velasquez, MD is a published physician. He has 86 publications published. The most current publication "Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy." He is registered with Medicare and accepts Medicare payments.
Publications
- Translocation (15;17) and trisomy 21 in the microgranular variant of acute promyelocytic leukemia.
- Stage I-II low-grade Lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
- Autologous bone marrow transplantation in solid Tumors.
- Campylobachter fetus infection in a patient with Hodgkin''s disease.
- Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
- Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
- Combined modality therapy in Stage III and Stage IIIE diffuse large cell Lymphomas.
- Hypercalcemia, unusual bone lesions, and human T-cell leukemia-Lymphoma virus in adult T-cell Lymphoma.
- Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.
- High-dose cytosine arabinoside in non-Hodgkin's Lymphoma.
- Treatment of stage I and II Mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by l...
- Results of a salvage treatment program for relapsing Lymphoma: MINE consolidated with ESHAP.
- Design of preparative regimens for stem cell transplantation in breast Cancer.
- Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determinin...
- A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory Lymphomas.
- Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem Cells: effects on hematopoietic recovery after high-dose chemotherapy.
- Topotecan, Ara-C, cisplatin and prednisolone (TOPOSHAP) for patients with refractory and relapsing Lymphomas: results of a phase I trial.
- Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade Lymphoma: S9501.
- Aggressive non-Hodgkin's Lymphomas in immunocompromised homosexual males.
- Primary Lymphomas of the nasal cavity and paranasal sinuses.
- Stage IV diffuse large-cell Lymphoma: a long-term analysis.
- Results of MIME salvage regimen for recurrent or refractory Lymphoma.
- Stage I-II follicular Lymphoma. Treatment results for 76 patients.
- Primary Lymphoma of the mandible.
- Activity of bisantrene in refractory Lymphoma.
- MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
- High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies.
- Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell Lymphoma and immunoblastic Lymphoma.
- Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.
- Effective salvage therapy for Lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).
- The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse Lymphomas as well as follicular Lymphomas.
- Stage III follicular Lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen.
- The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
- Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal Brain lymphoma.
- Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia.
- Results of recent salvage chemotherapy regimens for Lymphoma and Hodgkin's disease.
- Thyroid Lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment.
- Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell Lymphoma.
- Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating f...
- Surgical debulking is associated with improved survival in stage I-II diffuse large cell Lymphoma.
- Small noncleaved cell Lymphoma in adults: superior results for stages I-III disease.
- Prognostic factors in aggressive Lymphoma.
- Prognostic value of serum beta-2 microglobulin in low-grade Lymphoma.
- Clinical, biologic, and histologic features of late relapses in diffuse large cell Lymphoma.
- Multivariate analysis of prognostic factors in stage IV follicular low-grade Lymphoma: a risk model.
- Stages I and II diffuse large cell Lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy.
- Stomach conservation in stages IE and IIE gastric non-Hodgkin's Lymphoma.
- Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease.
- Therapy of relapsed or refractory low-grade follicular Lymphomas: factors associated with complete remission, survival and time to treatment failure.
- Phase II trial of fludarabine phosphate in Lymphoma: an effective new agent in low-grade Lymphoma.
- Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell Lymphoma treated with CHOP-Bleo and radiation.
- Intermediate-grade Lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexame...
- Randomized study of growth factors post-peripheral-blood stem-Cell transplant: neutrophil recovery is improved with modest clinical benefit.
- Reassessment of prognostic factors in stage IIIA and IIIB Hodgkin's disease treated with MOPP and radiotherapy.
- Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
- The roles of staging laparotomy, chemotherapy, and radiotherapy in the management of localized diffuse large cell Lymphoma: a study of 75 patients.
- Stage III nodular Lymphomas. Preliminary results of a combined chemotherapy/radiotherapy program.
- Treatment of patients with stages I and II nonMediastinal Hodgkin's disease.
- Recurrent Salmonella meningitis in a compromised host.
- Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
- Clinical features and results of management of superior vena cava Syndrome secondary to lymphoma.
- Use of intravenous liposoluble contrast material for the examination of the liver and spleen in Lymphoma.
- Stages IE and IIE non-Hodgkin's Lymphomas of the stomach. Comparison of treatment modalities.
- Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin''s disease.
- Discordant bone marrow involvement in diffuse large-cell Lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.
- Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma.
- Risk classification as the basis for clinical staging of diffuse large-cell Lymphoma derived from 10-year survival data.
- A new serologic staging System for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
- Hodgkin's disease and non-Hodgkin's Lymphomas.
- Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgk...
- Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin.
- Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem Cell transplantation: a retrospective...
- Multiple myeloma with monoclonal surface immunoglobulin expression: a case report.
- Risk classification for large cell Lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.
- ESHAP--an effective chemotherapy regimen in refractory and relapsing Lymphoma: a 4-year follow-up study.
- Prognostic factors in intermediate high grade Lymphoma.
- Tandem transplants in solid tumors: marrow versus peripheral stem Cell transplant: peripheral blood Cells as now practiced are not the whole answer.
- CHOP-Bleo plus interferon for stage IV low-grade Lymphoma.
- Natural killer Cell lymphoproliferative disorder of granular lymphocytes presenting as hemolytic anemia: case report and review of the literature.
- [Lymphoma].
- Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
- Hodgkin''s disease: study of treatment intensities and incidences of second malignancies.
- Rituximab therapy in Waldenstrom''s macroglobulinemia: preliminary evidence of clinical activity.
- Pegaspargase versus asparaginase in adult ALL: a pharmacoeconomic assessment.
Schools
Universidad Nacional Mayor De San Marcos Facultad De Medicina
Meml Hosp
Cincinnati
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Antiphospholipid Syndrome (APS)
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Adult Hematology
- Medical Oncology
- Hematology
Accepted Insurances
Awards
- Fellow (FACP)
Education
-
University of Texas MD Anderson Cancer Center -
University Hospital - University of Cincinnati College of Medicine -
National University of San Marcos
Hospital
-
Memorial Hermann Memorial City Medical Center -
Baylor St. Luke's Medical Center
Drug Facts
| NPI NUMBER | 1346201175 | |
| NPPES Provider LastName | VELASQUEZ | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 770741807 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1025.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 46.0 | |
| Percent Opioid Claims | 4.49 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346201175 |
| Last Name Of The Provider | VELASQUEZ |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
Dr. Luis T. Campos, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Nabeel K. Shalan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Arvind Bhandari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anupama Pant Dhodapkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meghana S. Bhandari, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nadeem Qurashi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles L. Conlon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Caesar K. Tin-U, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asha Murthy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Owen B. Ellington, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jackie Nguyen, DO |
|
Dr. Devesh M. Pandya, MD
This Doctor is OpenDoctor Recommended.
|